John Hunter Hospital ( Site 0203)

Newcastle, New South Wales 2305

0 studies enrolling now · 1 studies all time

What they study most

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

Studies at this site

• A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006) — Running, not enrolling